Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongtai International Financial Holding Limited is a comprehensive financial services institution based in Hong Kong and serves as the international arm of the mainland Chinese brokerage Zhongtai Securities. The firm provides a diverse suite of services including investment banking, asset management, wealth management, and brokerage services to global and regional clients. While not a life sciences company by primary function, it is a prominent player in the healthcare ecosystem through its role as a leading underwriter and sponsor for biotechnology and pharmaceutical IPOs on the Hong Kong Stock Exchange. The company facilitates capital raising and strategic financial advisory for emerging healthcare firms seeking to transition from private to public markets. By leveraging its deep connections in mainland China and its expertise in the Hong Kong regulatory environment, Zhongtai International acts as a critical bridge for Chinese healthcare enterprises entering the international capital markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhong Tai International Financial Holdings.